Compare $COO vs $HAE | Chartloom

Compare

$COO vs $HAE

Cooper Companies Inc · Haemonetics Corp

COO

Cooper Companies Inc

HAE

Haemonetics Corp

Compare $COO vs $HAE

Comparing Cooper Companies Inc and Haemonetics Corp

COOCooper Companies Inc

HAEHaemonetics Corp

COOCooper Companies Inc

Market cap

$10.60B

P/E (TTM)

18.44x

Forward P/E (NTM)

11.85x

Forward P/S (NTM)

2.41x

Rev growth (TTM)

4.7%

YTD performance

-33.0%

52W performance

-22.6%

FCF yield

6.4%

HAEHaemonetics Corp

Market cap

$5.39B

P/E (TTM)

56.34x

Forward P/E (NTM)

21.33x

Forward P/S (NTM)

3.72x

Rev growth (TTM)

0.4%

YTD performance

48.4%

52W performance

132.8%

FCF yield

4.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

COO

HAE

Detailed metrics comparison

COO

Cooper Companies Inc

HAE

Haemonetics Corp

Market Cap

COO$10.60B

HAE$5.39B

Enterprise Value

COO$12.99B

HAE$6.35B

Price

COO$54.37

HAE$118.69

P/E Ratio

COO18.44x

HAE56.34x

P/S Ratio

COO2.50x

HAE3.99x

EV/Sales

COO3.07x

HAE4.69x

EV/EBITDA

COO14.00x

HAE17.94x

P/B Ratio

COO1.30x

HAE5.69x

P/FCF Ratio

COO15.64x

HAE22.00x

EV/FCF

COO19.16x

HAE25.88x

PEG Ratio

COO3.49x

HAEN/A

Forward P/E (NTM)

COO11.85x

HAE21.33x

Forward P/S (NTM)

COO2.41x

HAE3.72x

Revenue (TTM)

COO$4.24B

HAE$1.35B

Revenue Growth (YoY)

COO4.7%

HAE0.4%

Forward Rev Growth

COO4.1%

HAE5.2%

Gross Margin (TTM)

COO65.9%

HAE59.1%

Operating Margin (TTM)

COO12.8%

HAE11.9%

EBITDA Margin (TTM)

COO21.9%

HAE26.2%

Net Margin (TTM)

COO13.5%

HAE7.1%

FCF Margin (TTM)

COO16.0%

HAE18.1%

Net Income (TTM)

COO$570M

HAE$96M

FCF (TTM)

COO$678M

HAE$245M

EPS (TTM)

COO$2.95

HAE$2.11

ROE (TTM)

COO6.9%

HAE11.3%

ROA (TTM)

COO4.6%

HAE4.0%

ROIC (TTM)

COO5.3%

HAE4.7%

Cash

COO$155M

HAE$223M

Debt

COO$2.54B

HAE$1.17B

Net Cash/Debt

COO$-2.39B

HAE$-951M

Current Ratio (TTM)

COO1.22x

HAE3.08x

Quick Ratio (TTM)

COO0.51x

HAE1.67x

Debt/Equity (TTM)

COO0.31x

HAE1.40x

Debt/Assets (TTM)

COO0.0%

HAE0.0%

Interest Coverage (TTM)

COON/A

HAEN/A

Net Debt/EBITDA (TTM)

COO0.00x

HAE0.00x

Beta

COO0.83

HAE0.62

52W Performance

COO-22.6%

HAE132.8%

YTD Performance

COO-33.0%

HAE48.4%

% from 52W High

COO-39.5%

HAE-2.1%

% from 52W Low

COO6.6%

HAE146.4%

Asset Turnover (TTM)

COO0.34x

HAE0.56x

FCF Yield (TTM)

COO6.4%

HAE4.5%

Earnings Yield (TTM)

COO5.4%

HAE1.8%

Dividend Yield (TTM)

COON/A

HAEN/A

Rule of 40

COO20.7

HAE18.6

EV/GP/RG

COO1.25

HAE1.08

Ticker research

View COO research View HAE research

Metric	COO Cooper Companies Inc	HAE Haemonetics Corp
Market & Valuation
Market Cap	$10.60B	$5.39B
Enterprise Value	$12.99B	$6.35B
Price	$54.37	$118.69
P/E Ratio	18.44x	56.34x
P/S Ratio	2.50x	3.99x
EV/Sales	3.07x	4.69x
EV/EBITDA	14.00x	17.94x
P/B Ratio	1.30x	5.69x
P/FCF Ratio	15.64x	22.00x
EV/FCF	19.16x	25.88x
PEG Ratio	3.49x	N/A
Forward P/E (NTM)	11.85x	21.33x
Forward P/S (NTM)	2.41x	3.72x
Revenue & Growth
Revenue (TTM)	$4.24B	$1.35B
Revenue Growth (YoY)	4.7%	0.4%
Forward Rev Growth	4.1%	5.2%
Profitability
Gross Margin (TTM)	65.9%	59.1%
Operating Margin (TTM)	12.8%	11.9%
EBITDA Margin (TTM)	21.9%	26.2%
Net Margin (TTM)	13.5%	7.1%
FCF Margin (TTM)	16.0%	18.1%
Net Income (TTM)	$570M	$96M
FCF (TTM)	$678M	$245M
EPS (TTM)	$2.95	$2.11
ROE (TTM)	6.9%	11.3%
ROA (TTM)	4.6%	4.0%
ROIC (TTM)	5.3%	4.7%
Financial Health
Cash	$155M	$223M
Debt	$2.54B	$1.17B
Net Cash/Debt	$-2.39B	$-951M
Current Ratio (TTM)	1.22x	3.08x
Quick Ratio (TTM)	0.51x	1.67x
Debt/Equity (TTM)	0.31x	1.40x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.83	0.62
52W Performance	-22.6%	132.8%
YTD Performance	-33.0%	48.4%
% from 52W High	-39.5%	-2.1%
% from 52W Low	6.6%	146.4%
Efficiency & Yields
Asset Turnover (TTM)	0.34x	0.56x
FCF Yield (TTM)	6.4%	4.5%
Earnings Yield (TTM)	5.4%	1.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	20.7	18.6
EV/GP/RG	1.25	1.08
Ticker research	View COO research	View HAE research

Valuation

P/E Ratio

COO

18.44x

HAE

56.34x

P/S Ratio

COO

2.50x

HAE

3.99x

EV/FCF

COO

19.16x

HAE

25.88x

Growth & revenue

Revenue Growth TTM

COO

4.7%

HAE

0.4%

Forward Revenue Growth

HAE

5.2%

COO

4.1%

Profitability & performance

Gross Margin

COO

65.9%

HAE

59.1%

ROE

HAE

11.3%

COO

6.9%

FCF Yield %

COO

6.4%

HAE

4.5%

52-Week Performance

HAE

132.8%

COO

-22.6%

Detailed metrics comparison

COO

Cooper Companies Inc

HAE

Haemonetics Corp

Market Cap

COO$10.60B

HAE$5.39B

Enterprise Value

COO$12.99B

HAE$6.35B

Price

COO$54.37

HAE$118.69

P/E Ratio

COO18.44x

HAE56.34x

P/S Ratio

COO2.50x

HAE3.99x

EV/Sales

COO3.07x

HAE4.69x

EV/EBITDA

COO14.00x

HAE17.94x

P/B Ratio

COO1.30x

HAE5.69x

P/FCF Ratio

COO15.64x

HAE22.00x

EV/FCF

COO19.16x

HAE25.88x

PEG Ratio

COO3.49x

HAEN/A

Forward P/E (NTM)

COO11.85x

HAE21.33x

Forward P/S (NTM)

COO2.41x

HAE3.72x

Revenue (TTM)

COO$4.24B

HAE$1.35B

Revenue Growth (YoY)

COO4.7%

HAE0.4%

Forward Rev Growth

COO4.1%

HAE5.2%

Gross Margin (TTM)

COO65.9%

HAE59.1%

Operating Margin (TTM)

COO12.8%

HAE11.9%

EBITDA Margin (TTM)

COO21.9%

HAE26.2%

Net Margin (TTM)

COO13.5%

HAE7.1%

FCF Margin (TTM)

COO16.0%

HAE18.1%

Net Income (TTM)

COO$570M

HAE$96M

FCF (TTM)

COO$678M

HAE$245M

EPS (TTM)

COO$2.95

HAE$2.11

ROE (TTM)

COO6.9%

HAE11.3%

ROA (TTM)

COO4.6%

HAE4.0%

ROIC (TTM)

COO5.3%

HAE4.7%

Cash

COO$155M

HAE$223M

Debt

COO$2.54B

HAE$1.17B

Net Cash/Debt

COO$-2.39B

HAE$-951M

Current Ratio (TTM)

COO1.22x

HAE3.08x

Quick Ratio (TTM)

COO0.51x

HAE1.67x

Debt/Equity (TTM)

COO0.31x

HAE1.40x

Debt/Assets (TTM)

COO0.0%

HAE0.0%

Interest Coverage (TTM)

COON/A

HAEN/A

Net Debt/EBITDA (TTM)

COO0.00x

HAE0.00x

Beta

COO0.83

HAE0.62

52W Performance

COO-22.6%

HAE132.8%

YTD Performance

COO-33.0%

HAE48.4%

% from 52W High

COO-39.5%

HAE-2.1%

% from 52W Low

COO6.6%

HAE146.4%

Asset Turnover (TTM)

COO0.34x

HAE0.56x

FCF Yield (TTM)

COO6.4%

HAE4.5%

Earnings Yield (TTM)

COO5.4%

HAE1.8%

Dividend Yield (TTM)

COON/A

HAEN/A

Rule of 40

COO20.7

HAE18.6

EV/GP/RG

COO1.25

HAE1.08

Ticker research

View COO research View HAE research

Metric	COO Cooper Companies Inc	HAE Haemonetics Corp
Market & Valuation
Market Cap	$10.60B	$5.39B
Enterprise Value	$12.99B	$6.35B
Price	$54.37	$118.69
P/E Ratio	18.44x	56.34x
P/S Ratio	2.50x	3.99x
EV/Sales	3.07x	4.69x
EV/EBITDA	14.00x	17.94x
P/B Ratio	1.30x	5.69x
P/FCF Ratio	15.64x	22.00x
EV/FCF	19.16x	25.88x
PEG Ratio	3.49x	N/A
Forward P/E (NTM)	11.85x	21.33x
Forward P/S (NTM)	2.41x	3.72x
Revenue & Growth
Revenue (TTM)	$4.24B	$1.35B
Revenue Growth (YoY)	4.7%	0.4%
Forward Rev Growth	4.1%	5.2%
Profitability
Gross Margin (TTM)	65.9%	59.1%
Operating Margin (TTM)	12.8%	11.9%
EBITDA Margin (TTM)	21.9%	26.2%
Net Margin (TTM)	13.5%	7.1%
FCF Margin (TTM)	16.0%	18.1%
Net Income (TTM)	$570M	$96M
FCF (TTM)	$678M	$245M
EPS (TTM)	$2.95	$2.11
ROE (TTM)	6.9%	11.3%
ROA (TTM)	4.6%	4.0%
ROIC (TTM)	5.3%	4.7%
Financial Health
Cash	$155M	$223M
Debt	$2.54B	$1.17B
Net Cash/Debt	$-2.39B	$-951M
Current Ratio (TTM)	1.22x	3.08x
Quick Ratio (TTM)	0.51x	1.67x
Debt/Equity (TTM)	0.31x	1.40x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.83	0.62
52W Performance	-22.6%	132.8%
YTD Performance	-33.0%	48.4%
% from 52W High	-39.5%	-2.1%
% from 52W Low	6.6%	146.4%
Efficiency & Yields
Asset Turnover (TTM)	0.34x	0.56x
FCF Yield (TTM)	6.4%	4.5%
Earnings Yield (TTM)	5.4%	1.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	20.7	18.6
EV/GP/RG	1.25	1.08
Ticker research	View COO research	View HAE research